Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04971681 · ClinicalTrials.gov registry record · NA
Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04971681 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 9 participants.
The verdict
NCT04971681, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This will be a single site randomized, 2-session, within-subject cross-over design pilot study. 20 enrolled (of 30 consented) subjects reporting varying levels of binge and high intensity drinking, defined as at least 2 episodes of drinking 4 (for women) or 5 (for men) drinks on an occasion over the last 5 weeks, (unless determined by PI that drinking history meets study objectives), will be enrolled. Subjects will be randomized to undergo one session of repetitive transcranial magnetic stimulation (rTMS) or sham immediately followed by the investigators rate control intravenous (IV) alcohol self-administration (ASA) paradigm. Subjects will then return 7-14 days later and undergo the same sequence of events with the opposite intervention (i.e. rTMS or sham) from session 1.
Interventions
- DEVICE Sham
- DEVICE Low frequency repetitive transcranial magnetic stimulation (rTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-10-08 |
| Est. Completion | 2022-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04971681
The ClinicalTrials.gov registry entry for NCT04971681 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT04971681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04971681 about?
NCT04971681 is a clinical study titled "Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration". This will be a single site randomized, 2-session, within-subject cross-over design pilot study. 20 enrolled (of 30 consented) subjects reporting varying levels of binge and high intensity drinking, defined as at least 2 episodes of drinking 4 (for women) or 5 (for men) drinks on an occasion over the...
What is the current status of trial NCT04971681?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2021-10-08. Estimated completion is 2022-06-02.
What interventions are being tested in trial NCT04971681?
The interventions under investigation include: Sham (DEVICE), Low frequency repetitive transcranial magnetic stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT04971681?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.